Professor Gregory Monteith
Professor

Gregory Monteith

Email: 
Phone: 
+61 7 334 61855

Background

Greg studies cellular signalling in disease and the identification of new drug targets. Greg leads the Calcium Signalling Therapeutics Team (CaSTT) in the School of Pharmacy at UQ.

His lab specializes in the development and application of genetically encoded calcium indicators for high-content imaging in live cells. His team focuses on integrating these technologies into high-throughput assays that are critical for drug discovery efforts targeting calcium-mediated signaling pathways. The group has developed and utilized high-content imaging platforms to investigate calcium signaling in various cell types. These platforms enable the team to conduct large-scale screenings and these have been instrumental in identifying novel therapeutic targets.

Greg has established a research program with research funding via NHMRC, ARC, Queensland Cancer Council, Society of Biomolecular Screening, Department of Defense (USA) and other grants and collaboration with Pharmaceutical companies. His interests are signal transduction in disease, calcium transporters as drug targets and biomolecular screening. His work has led to patents and projects towards commercialization for new therapies for cancer.

In 2006 he received a UQ Foundation research excellence award and in 2016 he received the UQ Research Higher Degree Supervision Excellence Award - video link. Greg has also recieved a Research Mentorship Award (HaBS, 2017) and an award for Excellence in Leadership (UQ, 2016).

Availability

Professor Gregory Monteith is:
Available for supervision

Fields of research

Biological Sciences Oncology and carcinogenesis Pharmacology and pharmaceutical sciences

Qualifications

  • Bachelor (Honours), University of Sydney
  • Doctor of Philosophy, University of Sydney

Research interests

  • calcium regulation in disease and cell signalling

    Our current projects are focussed on the study of a variety of calcium transporters in disease for the identification of novel drug targets. PhD and Post-doctoral opportunities may be available, contact - gregm@uq.edu.au and see the "available projects" link.

  • High throughput calcium assays for biomolecular screening and cancer research

    Our laboratory has the the first FLIPR-tetra system in Australia, allowing high throughput measurement of intracellular calcium in living cells.

Search Professor Gregory Monteith’s works on UQ eSpace

419 works between 1992 and 2024
All (419) Journal Article (138) Book Chapter (7) Conference Publication (273) Other Outputs (1)

301 - 320 of 419 works

2006

Conference Publication

Preliminary evaluation of cultured embryonic rat midbrain neurons as an in vitro model of diabetic neuropathy

Tsui, D. Y., Monteith, G. R., Wyse, B. D. and Smith, M. T. (2006). Preliminary evaluation of cultured embryonic rat midbrain neurons as an in vitro model of diabetic neuropathy. 11th World Congress on Pain, Sydney, Australia, 21-26 August 2005. Seattle, Wa.: IASP Press.

Preliminary evaluation of cultured embryonic rat midbrain neurons as an in vitro model of diabetic neuropathy

2006

Journal Article

Isoform specific changes in PPAR alpha and beta in colon and breast cancer with differentiation

Aung, CS, Faddy, HM, Lister, EJ, Monteith, GR and Roberts-Thomson, SJ (2006). Isoform specific changes in PPAR alpha and beta in colon and breast cancer with differentiation. Biochemical And Biophysical Research Communications, 340 (2), 656-660. doi: 10.1016/j.bbrc.2005.12.061

Isoform specific changes in PPAR alpha and beta in colon and breast cancer with differentiation

2006

Conference Publication

Muscarinic agonist-induced recruitment of PMCA to themembrance involves the PDZ scaffold NA+ H+ exchanger regulatory factor 2 (NHERF-2)

Kruger, W. A., Monteith, G R and Poronnik, P (2006). Muscarinic agonist-induced recruitment of PMCA to themembrance involves the PDZ scaffold NA+ H+ exchanger regulatory factor 2 (NHERF-2). ComBio 2006, Brisbane Convention Centre, Brisbane, Australia, 24-28 September, 2006. Kent Town, South Australia: Australian Society for Biochemistry and Molecular Biology.

Muscarinic agonist-induced recruitment of PMCA to themembrance involves the PDZ scaffold NA+ H+ exchanger regulatory factor 2 (NHERF-2)

2006

Conference Publication

Peroxisome-proliferator activated receptor (PPAR) beta/delta and its role inr elapsing-remitting experimental autoimmune encephalomyelitis (RR-EAE)

Peiris, M., Monteith, G. R., Roberts-Thomson, S. J. and Cabot, P. J. (2006). Peroxisome-proliferator activated receptor (PPAR) beta/delta and its role inr elapsing-remitting experimental autoimmune encephalomyelitis (RR-EAE). Neuroscience 2006, Georgia World Congress Center / Altana, Georgia, U.S.A., 11-18 October, 2006. Washington, D.C. U.S.A.: Society for Neuroscience.

Peroxisome-proliferator activated receptor (PPAR) beta/delta and its role inr elapsing-remitting experimental autoimmune encephalomyelitis (RR-EAE)

2006

Conference Publication

Plasma membrane calcium pump (PMCA) expression in a colon cancer cell line during differentiation

Aung, C. S., Monteith, G. R. and Roberts-Thomson, S. J. (2006). Plasma membrane calcium pump (PMCA) expression in a colon cancer cell line during differentiation. ComBio 2006, Brisbane Convention Centre, Brisbane, Australia, 24-28 September, 2006. Kent Town, South Australia: Australian Society for Biochemistry and Molecular Biology.

Plasma membrane calcium pump (PMCA) expression in a colon cancer cell line during differentiation

2006

Journal Article

Anti-proliferative effects of novel Glyco-lipid-arsenicals (III) on MCF-7 human breast cancer cells

Wimmer, N., Robinson, J. A., Gopisetty Venkata, N., Roberts-Thomson, S. J., Monteith, G. R. and Toth, I. (2006). Anti-proliferative effects of novel Glyco-lipid-arsenicals (III) on MCF-7 human breast cancer cells. Medicinal Chemistry, 2 (1), 79-87. doi: 10.2174/157340606775197714

Anti-proliferative effects of novel Glyco-lipid-arsenicals (III) on MCF-7 human breast cancer cells

2006

Book Chapter

Fluorescence microplate-based techniques for the high-throughput assessment of calcium signaling: The highs and lows for calcium researchers

Monteith, G. R. and Bird, G.S.J. (2006). Fluorescence microplate-based techniques for the high-throughput assessment of calcium signaling: The highs and lows for calcium researchers. Calcium Signaling. (pp. 85-99) edited by J.W. Putney Jr. USA: CRC Press. doi: 10.1201/9781420038231

Fluorescence microplate-based techniques for the high-throughput assessment of calcium signaling: The highs and lows for calcium researchers

2006

Conference Publication

Characterization of transient receptor potential cation channels V1 and V6 in human breast cancer cells

McAndrew, D. V., Roberts-Thomson, S. J. and Monteith, G. R. (2006). Characterization of transient receptor potential cation channels V1 and V6 in human breast cancer cells. The 3rd Australian Health & Medical Research Congress, Melbourne Convention Centre, Melbourne, Australia, 26 November-1 December, 2006. Sydney, N.S.W., Australia: National Health and Medical Research Council.

Characterization of transient receptor potential cation channels V1 and V6 in human breast cancer cells

2006

Conference Publication

Norathyriol, the active metabolite of mangiferin, modulates PPAR activity and is a potential nutritional bioactive

Wilkinson, A. S., Lin, C. N., Dietzgen, R. G., Monteith, G. R., Shaw, P. N., Roberts-Thomson, S. J. and Gidley, M. (2006). Norathyriol, the active metabolite of mangiferin, modulates PPAR activity and is a potential nutritional bioactive. Annual Conference of the Australasian Pharmaceutical Science Association, Adelaide Hilton, Adelaide, South Australia, 3-5 December, 2006. Malvern,Vic, Australia: Australasian Pharmaceutical Science Association.

Norathyriol, the active metabolite of mangiferin, modulates PPAR activity and is a potential nutritional bioactive

2006

Conference Publication

The effects of mono (2-ethylhexyl) phthalate, mono-n-butyl phthalate and ethanol on PPARs in MCF-7 human breast cancer cells

Gopisetty Venkata, N., Robinson, J. A., Cabot, P. J., Monteith, G. R. and Roberts-Thomson, S. J. (2006). The effects of mono (2-ethylhexyl) phthalate, mono-n-butyl phthalate and ethanol on PPARs in MCF-7 human breast cancer cells. AACR 97th Annual Meeting 2006: Driving the science: From bench to bedside...and back, Washington, DC, U.S.A., 1-5 April, 2006. Philadelphia, PA, U.S.A.: American Association for Cancer.

The effects of mono (2-ethylhexyl) phthalate, mono-n-butyl phthalate and ethanol on PPARs in MCF-7 human breast cancer cells

2006

Conference Publication

Novel glyco-lipid-arsenicals(III) with anti-proliferative effects on MCF-7 human breast cancer cells

Wimmer, N, Robinson, JA, Gopisetty-Venkatta, N, Roberts-Thomson, SJ, Monteith, GR and Toth, I (2006). Novel glyco-lipid-arsenicals(III) with anti-proliferative effects on MCF-7 human breast cancer cells. 19th American Peptide Symposium, San Diego, CA, United States, June 18-23 2005. New York, N.Y., United States: Springer. doi: 10.1007/978-0-387-26575-9_148

Novel glyco-lipid-arsenicals(III) with anti-proliferative effects on MCF-7 human breast cancer cells

2006

Conference Publication

Modulation of TRPV1-mediated capsaicin responses potentiated through PKC and camp-dependent PKA pathways by the Mu opioid receptor agonist morphine

Vetter, I., Wyse, B. D., Monteith, G. R., Roberts-Thomson, S. J. and Cabot, P. J. (2006). Modulation of TRPV1-mediated capsaicin responses potentiated through PKC and camp-dependent PKA pathways by the Mu opioid receptor agonist morphine. ComBio 2006, Brisbane Convention Centre, Brisbane, Australia, 24-28 September, 2006. Kent Town, South Australia: Australian Society for Biochemistry and Molecular Biology.

Modulation of TRPV1-mediated capsaicin responses potentiated through PKC and camp-dependent PKA pathways by the Mu opioid receptor agonist morphine

2006

Conference Publication

PRG100, a novel anti-allodynic agent

Tsui, D. Y. Y., Wyse, B. D., Monteith, G. R. and Smith, M. T. (2006). PRG100, a novel anti-allodynic agent. 26th Annual Scientific Meeting of the Australian Pain Society, Melbourne, Australia, 9-12 April, 2006. Victoria, Australia: Australian Pain Society.

PRG100, a novel anti-allodynic agent

2006

Conference Publication

Nutritional bioactives in tropical fruit

Wilkinson, A, Hewavitharana, A, Flanagan, B M, Dietzgen, R G, Monteith, G R, Shaw, P N, Roberts-Thomson, S J and Gidley, M (2006). Nutritional bioactives in tropical fruit. The 3rd Australian Health & Medical Research Congress, Melbourne Convention Centre, Melbourne, Australia, 26 November-1 December, 2006. Melbourne, Vic, Australia: National Health and Medical Research Council.

Nutritional bioactives in tropical fruit

2006

Conference Publication

The effects of ethanol on PPARS in MCF-7 human breast cancer cells

Gopisetty Venkata, N., Cabot, P. J., Monteith, G. R. and Roberts-Thomson, S. J. (2006). The effects of ethanol on PPARS in MCF-7 human breast cancer cells. ComBio 2006, Brisbane Convention Centre, Brisbane, Australia, 24-28 September, 2006. Kent Town, South Australia: Australian Society for Biochemistry and Molecular Biology.

The effects of ethanol on PPARS in MCF-7 human breast cancer cells

2005

Journal Article

Consumer involvement in quality use of medicines (QUM) projects - lessons from Australia

Kirkpatrick, Carl M. J., Roughead, Elizabeth E., Monteith, Gregory R. and Tett, Susan E. (2005). Consumer involvement in quality use of medicines (QUM) projects - lessons from Australia. BMC Health Services Research, 5 (1) 75, 75.1-75.7. doi: 10.1186/1472-6963-5-75

Consumer involvement in quality use of medicines (QUM) projects - lessons from Australia

2005

Journal Article

Techniques: High-throughput measurement of intracellular Ca2+ – back to basics

Monteith, Gregory R. and Bird, Gary St J. (2005). Techniques: High-throughput measurement of intracellular Ca2+ – back to basics. Trends in Pharmacological Sciences, 26 (4), 218-223. doi: 10.1016/j.tips.2005.02.002

Techniques: High-throughput measurement of intracellular Ca2+ – back to basics

2005

Conference Publication

The plasma membrane calcium pump in MCF-7 breast cancer cells

Lee, W. J., Roberts-Thomson, S. J., Robinson, J. A. and Monteith, G. R. (2005). The plasma membrane calcium pump in MCF-7 breast cancer cells. American Association for Cancer Research - 96th Annual Meeting, Anaheim, CA, U.S.A., 16-20 April, 2005. Philadelphia, PA, U.S.A.: Cadmus Professional Communications.

The plasma membrane calcium pump in MCF-7 breast cancer cells

2005

Conference Publication

Acidic pH enhances morphine inhibition of high-K2+ induced Ca2+ responses in dorsal root ganglion neurons

Kapitzke, D., Hermanussen, S.F., Jenkins, N., Hua, S., Vetter, I., Monteith, G.R. and Cabot, P.J. (2005). Acidic pH enhances morphine inhibition of high-K2+ induced Ca2+ responses in dorsal root ganglion neurons. 11th World Congress on Pain, Sydney, NSW, Australia, 21-26 August, 2005. Seattle, WA, U.S.A.: IASP Press.

Acidic pH enhances morphine inhibition of high-K2+ induced Ca2+ responses in dorsal root ganglion neurons

2005

Conference Publication

Calcium transporters in breast cancer

Faddy, H. M., Lee, W. J., Roberts-Thomson, S. J. and Monteith, G. R. (2005). Calcium transporters in breast cancer. Joint Meeting of ASCEPT and APSA, Melbourne, Vic, Australia, 4-7 December, 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.

Calcium transporters in breast cancer

Current funding

  • 2025 - 2028
    A First-in-Class Calcium Channel Inhibitor for the Treatment of Advanced Metastatic Prostate Cancers Resistant to Next-Generation Antiandrogen Therapy
    United States Congressionally Directed Medical Research Programs - Prostate Cancer Research Program
    Open grant
  • 2023 - 2026
    A calcium influx pathway regulates adaptive cancer drug tolerance
    NHMRC IDEAS Grants
    Open grant

Past funding

  • 2023 - 2024
    A calcium influx pathway regulates adaptive cancer drug tolerance
    TdC Pioneering Grant
    Open grant
  • 2022 - 2025
    An active ion transport pathway exploited by coronaviruses
    ARC Discovery Projects
    Open grant
  • 2020 - 2024
    Deciphering and intercepting messages between cancer cells and cells in the breast cancer microenvironment: Roles for intracellular calcium signaling
    United States Congressionally Directed Medical Research Programs - Breast Cancer Research Program
    Open grant
  • 2020 - 2023
    A recently identified calcium channel provides diverse opportunities for pharmacotherapy in breast cancer
    NHMRC IDEAS Grants
    Open grant
  • 2019 - 2021
    Exploiting remodelling of calcium signalling to specifically target triple negative breast cancer via promotion of apoptosis
    Cancer Council Queensland
    Open grant
  • 2018 - 2024
    Australian Red Cross Blood Service Chair in Donor Behaviour
    Australian Red Cross Blood Service
    Open grant
  • 2018 - 2021
    Calcium cycling and heat generation in skeletal muscle fibres
    ARC Discovery Projects
    Open grant
  • 2018
    High-throughput ion channel pharmacology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2020
    Pharmacological targeting of an adaptive breast cancer cell survival pathway as a novel treatment for breast cancer: Constitutive Ca2+ influx mechanisms in triple negative breast cancer cells
    Cancer Council Queensland
    Open grant
  • 2017 - 2021
    Exploiting the Remodeling of Ca2+ Signaling in Breast Cancer Cell Microenvironments to Control Metastasis and to Specifically Target Brain Metastases
    United States Congressionally Directed Medical Research Programs - Breast Cancer Research Program
    Open grant
  • 2015 - 2021
    Collaborative Grants between WMHHS and University of Queensland
    West Moreton Hospital and Health Service
    Open grant
  • 2015 - 2017
    Exploiting the overexpression of a specific calcium permeable ion channel in breast cancer cells: a new pharmacological approach to targeting breast cancer.
    NHMRC Project Grant
    Open grant
  • 2015 - 2018
    Resistance to Herceptin (trastuzumab) in HER2 positive breast cancers: the role of calcium signalling
    NHMRC Project Grant
    Open grant
  • 2015
    The assessment of mitochondrial oxygen consumption and cytoplasmic glycolysis in cells to identify and characterize new therapeutic targets for diseases
    UQ Major Equipment and Infrastructure
    Open grant
  • 2014
    A medium-throughput cell isolation and analysis suite
    UQ Major Equipment and Infrastructure
    Open grant
  • 2013 - 2014
    QUE ORAI1 PROJECT
    Cancer Bequest Fund
    Open grant
  • 2013 - 2014
    Identification and characterisation of calcium signalling modifying proteins as drug targets for basal breast cancer
    Cancer Council Queensland
    Open grant
  • 2012 - 2015
    Calcium signaling and epithelial-mesenchymal transition: a new approach to identifying pharmacological targets for metastasis
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    The development of store operated calcium channel monoclonal antibody inhibitors as a therapeutic option for breast cancer treatment
    NHMRC Development Grant
    Open grant
  • 2011
    Establishment of a robotic liquid handling platofrm for the use of 384 and 1536 well plates
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    Cost effective acquisition of an LC-MS/MS system to support CIPDD organics analysis and preclinical and clinical operations
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    High content imaging analysis for bioactive and novel therapeutic target evaluation
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010 - 2013
    Two recently identified calcium transporters in lactation and during mammary epithelial cell apoptosis.
    NHMRC Project Grant
    Open grant
  • 2009 - 2011
    QUMmap and website
    Department of Health and Ageing (Commonwealth of Australia)
    Open grant
  • 2009 - 2010
    Multiphoton microscopy of living animals as a tool for immunology and cell biology studies
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2009
    A core pharmacy facility for molecular biology, expression and protein post translational modification studies in cancer, cardiovascular, pain and epilepsy research
    UQ School/Centre Co-Funding
    Open grant
  • 2009 - 2012
    Calcium Influx Pathways and Breast Cancer
    NHMRC Project Grant
    Open grant
  • 2009
    Robotics Instrumentation for High Throughput Sample preparation for Increased Productivity of the CIPDD/TetraQ's HPLC-MS/MS Systems for Quantitative Analysis of Organics in a Quality Systems NATA-Acc
    UQ Faculty Co-Funding
    Open grant
  • 2009 - 2011
    Secretory pathway calcium regulation and breast cancer
    Cancer Council Queensland
    Open grant
  • 2008 - 2011
    Nutritional properties of mango fruits: linking plant genomics to cellular bioactivities
    ARC Linkage Projects
    Open grant
  • 2008 - 2010
    Partnerships in Health Research Collaborative Challenge - Pick your Partners!
    Cancer Bequest Fund
    Open grant
  • 2008 - 2009
    QUMmap and Website June 2008
    Department of Health and Ageing (Commonwealth of Australia)
    Open grant
  • 2006 - 2007
    Calcium transporters and breast cancer: exploiting the link for new pharmaceutically relevant drug targets.
    UQ Foundation Research Excellence Awards - DVC(R) Funding
    Open grant
  • 2006 - 2008
    Maintenance and Promotion of the QUMMAP
    Department of Health and Ageing
    Open grant
  • 2005 - 2008
    Identification of nutritional bioactives in tropical fruit
    ARC Linkage Projects
    Open grant
  • 2005
    Establishment of an improved model of relapsing MS and the characterisation of the role of Peroxisome Proliferator - activated receoptors alpha and beta
    Multiple Sclerosis Research Australia
    Open grant
  • 2005
    Ethanol, PPARb and Breast Cancer
    Australian Brewers' Foundation
    Open grant
  • 2005
    NHMRC_Equipment Grant = DSI Telemetry System
    NHMRC Equipment Grant
    Open grant
  • 2005
    Uncharacterized Calcium Transporters as Targets for Disease: Training of a Pharmacy Student in Drug Target Identification and Characterization
    Pharmaceutical Society of Australia
    Open grant
  • 2004 - 2005
    NHMRC_Equipment Grant_HLTH_Pharmacy
    NHMRC Equipment Grant
    Open grant
  • 2004
    PPARb In Breast Cancer: Gene Transcription And Molecular Mechanisms
    University of Queensland Research Development Grants Scheme
    Open grant
  • 2004
    Role Of Plasma Membrane Ca Pump In High Glucose Induced Changes In Ca Signalling
    University of Queensland Research Development Grants Scheme
    Open grant
  • 2003 - 2004
    Assessment of Ca2+ levels in subcellular organelles and the activity of Ca2+ efflux pathways using fluorescence didgital imaging techniques: Application to high throughput screening
    Society for Biomolecular Screening
    Open grant
  • 2003
    Development of high-throughput assays for the identification of novel anticancer agents.
    Pharmaceutical Society of Australia
    Open grant
  • 2003
    Malvern Zetasizer 3000HS
    NHMRC Equipment Grant
    Open grant
  • 2003
    Unprecedented Alkaloid Hybrids that Selectively Modulate Various Cancers and the Central Nervous System
    University of Queensland Research Development Grants Scheme
    Open grant
  • 2002 - 2003
    The Maintenance and promotion of the quality use of medicines mapping project website.
    Department of Health and Ageing
    Open grant
  • 2002
    Funding for molecular biology computer software
    Brain Research Fund
    Open grant
  • 2002 - 2003
    Pharmacological investigation of the toxicological effects of high doses of systemic morphine
    Queensland Cancer Fund
    Open grant
  • 2002 - 2003
    The plasma membrane calcium ATPase (PMCA) in breast tumorigenic cells
    Queensland Cancer Fund
    Open grant
  • 2001 - 2002
    NHMRC Equipment Grant 2000
    NHMRC Equipment Grant
    Open grant
  • 2001
    A biohazard laminar flow hood for neuronal cell cultures:partial cost recovery from emergency purchase
    Brain Research Fund
    Open grant
  • 2001
    Partial funding to purchase a Biohazard II laminar flow hood.
    Pharmaceutical Society of Australia
    Open grant
  • 2001
    The plasma membrane Ca2+-ATPase (PMCA) in human mammary gland tumorigenesis
    Cancer Bequest Fund
    Open grant
  • 2000
    The regulation of mitochondrial calcium in tumorigenic and non-tumorigenic breast epithelial cells
    Pharmaceutical Society of Australia
    Open grant
  • 2000
    What are the consequences of plasma membrane calcium pump inhibition? implications for calcium homeostasis, proliferation and apoptosis.
    ARC Australian Research Council (Small grants)
    Open grant
  • 1999
    Expression of the plasma membrane calcium pump during hypoxia and ischemia
    Pharmaceutical Society of Australia
    Open grant
  • 1999
    PPAR and neurotoxicity
    Brain Research Fund
    Open grant
  • 1999 - 2001
    The plasma membrane calcium pump as a target for inhibition by tyrosine kinase phosphorylation: implications for cardiovascular disease
    National Heart Foundation of Australia
    Open grant
  • 1999
    The use of fluorescence microscopy to investigate the role of the calcium pump in disease and the mechanism of excitatory side effects by high dose morphine
    Ramaciotti Foundation
    Open grant
  • 1999
    Travel costs to neurosciences meeting 1999
    Potter Foundation
    Open grant
  • 1998
    Regulation of calcium pumps in smooth muscle
    Pharmaceutical Society of Australia
    Open grant

Availability

Professor Gregory Monteith is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Calcium signalling pathways in cancer progression

  • Calcium signalling changes associated with viral infection

  • Calcium channels and pumps as drug targets

  • Design of innovative high throughput methods for drug screening and testing

Supervision history

Current supervision

  • Doctor Philosophy

    Calcium signalling and cell death pathways in breast cancer cells

    Principal Advisor

    Other advisors: Dr Melanie Robitaille

  • Doctor Philosophy

    Calcium signalling in the context of cell in cell structures in a model of entosis in breast cancer cells

    Principal Advisor

    Other advisors: Dr Melanie Robitaille

  • Doctor Philosophy

    A Recently Identified Calcium Channel Provides Diverse Opportunities for Pharmacotherapy in Breast Cancer

    Associate Advisor

    Other advisors: Dr Ben Ross

  • Doctor Philosophy

    A Recently Identified Calcium Channel Provides Diverse Opportunities for Pharmacotherapy in Breast Cancer

    Associate Advisor

    Other advisors: Dr Ben Ross

  • Doctor Philosophy

    Development of a new approach to target exosomes for cancer treatment

    Associate Advisor

    Other advisors: Dr Sherry Wu

  • Doctor Philosophy

    The intersection between calcium signaling pathways and coronavirus infection

    Associate Advisor

    Other advisors: Dr Larisa Labzin, Dr Melanie Robitaille

  • Master Philosophy

    Investigating the role of exosomes in cancer progression and immunology

    Associate Advisor

    Other advisors: Dr Sherry Wu

  • Doctor Philosophy

    he intersection between calcium signaling pathways and viral infection

    Associate Advisor

    Other advisors: Dr Larisa Labzin, Dr Melanie Robitaille

Completed supervision

Enquiries

For media enquiries about Professor Gregory Monteith's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au